SEC Comment Letter for IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — Jan 6, 2009
IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: Jan. 6, 2009 · CIK: 0001326205 · Accession: 0000000000-09-000597
AI Filing Summary & Sentiment
Reasoning
Letter
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549-7010 DIVISION OF CORPORATION FINANCE Mail Stop 7010 January 6, 2009 via U.S. mail and facsimile Mr. Ram Mukunda President and CEO India Globalization Capital, Inc. 4336 Montgomery Ave. Bethesda, MD 20814 RE: Form 8-K Item 4.01 filed May 8, 2008 Form 8-K/A Item 4.01 filed May 22, 2008 File #1-32830
Dear Mr. Mukunda: We issued comments to you on the above captioned filings on May 14, 2008 and December 17, 2008. As of the date of this le tter, these comments remain outstanding and unresolved. We expect you to provide a substantive response to these comments by January 20, 2009. If you do not provide a substantive response to the outstanding comments by January 20, 2009, we will, consistent with our obligations under the federal securities laws, decide how we will seek to resolve material outstanding comments and complete our review of your filings and your disclosu re. Among other things, we may decide to release publicly, through the ag ency’s EDGAR system, all correspondence, including this letter, relating to the review of your filings, consistent with the staff’s decision to release publicly comment letters and response letters relating to disclosure filings it has reviewed. You can find more information a bout the staff’s decision to release filing correspondence at http://www.sec.gov/news/press/2004-89.htm and http://www.sec.gov/news/press/2005-72.htm .
Please contact Jeffrey Gordon, Staff A ccountant at (202) 551-3866 if you have any questions. S i n c e r e l y , R u f u s D e c k e r Accounting Branch Chief
Show Raw Text
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-7010
DIVISION OF
CORPORATION FINANCE
Mail Stop 7010
January 6, 2009
via U.S. mail and facsimile
Mr. Ram Mukunda President and CEO India Globalization Capital, Inc. 4336 Montgomery Ave. Bethesda, MD 20814
RE: Form 8-K Item 4.01 filed May 8, 2008
Form 8-K/A Item 4.01 filed May 22, 2008
File #1-32830
Dear Mr. Mukunda: We issued comments to you on the above captioned filings on May 14, 2008 and December 17, 2008. As of the date of this le tter, these comments remain outstanding and
unresolved. We expect you to provide a substantive response to these comments by January 20, 2009. If you do not provide a substantive response to the outstanding comments by
January 20, 2009, we will, consistent with our obligations under the federal securities
laws, decide how we will seek to resolve material outstanding comments and complete our review of your filings and your disclosu re. Among other things, we may decide to
release publicly, through the ag ency’s EDGAR system, all correspondence, including this
letter, relating to the review of your filings, consistent with the staff’s decision to release
publicly comment letters and response letters relating to disclosure filings it has reviewed. You can find more information a bout the staff’s decision to release filing
correspondence at http://www.sec.gov/news/press/2004-89.htm
and
http://www.sec.gov/news/press/2005-72.htm .
Please contact Jeffrey Gordon, Staff A ccountant at (202) 551-3866 if you have
any questions. S i n c e r e l y , R u f u s D e c k e r Accounting Branch Chief